Cite
MLA Citation
Jashin J. Wu et al.. “Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis.” Journal of dermatological treatment, vol. 32, 2021, pp. 693–700. http://access.bl.uk/ark:/81055/vdc_100144247852.0x00003c